Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI reads scans to forecast Crohn's complications

NCT ID NCT07757217

Knowledge-focused Sponsor: Shanghai 10th People's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study is testing whether an artificial intelligence system can more accurately classify small bowel Crohn's disease and predict how patients will fare over the next year. Researchers will analyze existing CT or MRI scans from 437 patients, combining imaging features with clinical, lab, and other data. The goal is to see if this AI approach can identify who might respond to medical treatment, who might need to switch therapies, and who may require surgery. This is an observational study, so no treatments are given; it aims to build a decision-support tool for doctors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Artificial intelligence-based multimodal analysis of existing imaging and clinical data
What this could lead to
If successful, this could lead to a tool that helps doctors personalize treatment decisions for small bowel Crohn's disease, potentially improving outcomes and reducing unnecessary surgeries.
What could go wrong
This is a retrospective observational study, so it cannot prove cause and effect. The AI model's accuracy may be limited by the quality and completeness of existing medical records, and results may not generalize to other hospitals or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

437 people

The number who actually took part.

Started

Jan 2020

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of patients with small bowel Crohn's disease who were hospitalized in the Department of Gastroenterology at Shanghai Tenth People's Hospital between January 1, 2020, and January 31, 2025. Eligible patients will be identified retrospectively from existing medical records. Patients must have adequate CTE or MRE images and sufficient clinical and follow-up information for multimodal feature extraction and assessment of subsequent treatment response, treatment switching, or Crohn's disease-related intestinal surgery.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of Crohn's disease established according to the European Crohn's and Colitis Organisation criteria based on clinical, endoscopic, radiological, and/or histopathological findings. * Small bowel involvement confirmed by computed tomography enterography, magnetic resonance enterography, endoscopy, surgery, and/or histopathology. * Availability of CTE or MRE images obtained before treatment and during follow-up. Follow-up imaging was performed within 6 months after treatment for patients with active disease or within 1 to 2 years for patients in remission. * Availability of sufficient clinical and follow-up information to determine treatment response, treatment switching, or Crohn's disease-related surgery. Exclusion Criteria: * Failure to receive regular medical treatment or follow-up. * Incomplete clinical or laboratory data that prevent assessment of the prespecified variables or clinical outcomes. * Poor-quality or incomplete CTE or MRE images that prevent reliable image segmentation or evaluation. * Presence of a malignant tumor. * Presence of severe comorbidities, including heart failure or other severe organ dysfunction, that may substantially affect clinical outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Crohn's disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Crohn disease small bowel Crohn disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Crohn's disease

Contacts and locations

Locations

  • The Tenth People's Hospital of Shanghai

    Shanghai, Shanghai Municipality, 201505, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.